How Risk-Taking Is Making a Comeback in Hollywood
In an industry long dominated by sequelitis and superhero capes, Hollywood appears to be rediscovering its adventurous spirit. Recent box office surprises and awards season darlings signal a shift: studios and filmmakers are gambling on original stories, unproven directors, and unconventional formats. From the body horror triumph of The Substance to the Palme d’Or-winning audacity of Anora, 2024 has showcased films that defy the franchise formula. This resurgence of risk-taking comes at a pivotal moment, as audiences crave novelty amid superhero fatigue and streaming saturation. Could this mark the end of the safe-bet era?
The catalyst? A string of high-profile flops from once-invincible IPs. Marvel’s The Marvels and DC’s The Flash underscored the diminishing returns of endless sequels, while even Indiana Jones and the Dial of Destiny stumbled. Meanwhile, bold bets like Christopher Nolan’s Oppenheimer—a three-hour biopic about a physicist—proved that audiences reward ambition. As we head into 2025, announcements from major studios reveal a willingness to back fresh visions, from Bong Joon-ho’s sci-fi mind-bender Mickey 17 to Ari Aster’s horror epic Eddington. Hollywood’s gamblers are betting big again.
This pivot feels like a breath of fresh air after years of formulaic fare. Data from Box Office Mojo highlights the trend: original films captured 28% of the top 10 domestic earners in 2024, up from 18% in 2022. Insiders point to evolving viewer habits—younger demographics on TikTok and Letterboxd demand the weird and wonderful—pushing executives to greenlight projects once deemed too risky.[1]
The Decline of the Franchise Fortress
Hollywood’s love affair with established IPs began in earnest post-2008 financial crash. Studios, scarred by the tanking of ambitious originals like John Carter, pivoted to sure things: Marvel’s interconnected universe minted billions, while Star Wars and Fast & Furious sequels kept cash flowing. By 2019, nine of the top 10 global earners were sequels or reboots. This strategy minimised risk but stifled creativity, leading to critic fatigue and audience burnout.
Fast-forward to 2024, and cracks abound. Warner Bros.’ Joker: Folie à Deux, a musical sequel to a billion-dollar hit, opened to a dismal $37 million domestically despite Lady Gaga’s star power. Disney’s live-action remakes, from Snow White delays to Mufasa: The Lion King‘s modest buzz, face scepticism. Paramount’s Mean Girls musical reboot succeeded modestly, but it highlighted the law of diminishing returns. Studios now realise that recycling IPs without innovation yields diminishing audiences.
Breakout Successes Lighting the Way
Enter the risk-takers who are thriving. A24’s The Substance, directed by Coralie Fargeat, blended graphic body horror with sharp satire on ageing Hollywood, grossing over $20 million on a $12 million budget. Its Cannes buzz and Demi Moore’s comeback propelled it to cult status, proving mid-budget genre films can profit handsomely. Similarly, Neon’s Anora, Sean Baker’s raw tale of a Brooklyn sex worker’s chaotic marriage, clinched the Palme d’Or and Palme d’Or du Jury, positioning it as an Oscars frontrunner.
Indie Engines Driving Change
Independents lead the charge. A24, fresh off Everything Everywhere All at Once‘s Best Picture win, boasts a 2025 slate including Bring Her Back (a haunted-house horror with twisted family dynamics) and Presence (a ghostly thriller from Steven Soderbergh). Neon follows with Babygirl, Nicole Kidman’s erotic thriller that premiered to raves at Venice. These films, often under $30 million, target passionate niche audiences before crossing over.
Major studios take note. Warner Bros. greenlit The Brutalist, a 215-minute epic from first-time feature director Brady Corbet about a Hungarian-Jewish architect’s American dream. Backed by a $20 million-plus budget and Adrien Brody, it debuted at Venice to 20-minute ovations. Sony’s The Amateur, a CIA revenge thriller starring Rami Malek, skips the IP crutch for a taut original script. Even Marvel dips a toe with Thunderbolts, blending anti-heroes in uncharted narrative territory.
Directors Daring to Dream Big
Visionary filmmakers embody this ethos. Bong Joon-ho’s Mickey 17, starring Robert Pattinson as a disposable space colonist who regenerates after death, reunites the Parasite Oscar winner with Warner Bros. after Snowpiercer. Its February 2025 release promises philosophical sci-fi unbound by franchise rules. Ari Aster, A24’s horror auteur, follows Midsommar and Beau Is Afraid with Eddington, a Western starring Joaquin Phoenix and Emma Stone amid ensemble weirdness.
Guy Ritchie’s The Ministry of Ungentlemanly Warfare already tested waters with its pulpy WWII action, outperforming expectations. Upcoming, his Alcaraz blends sports drama with crime. Denis Villeneuve’s Dune Messiah risks escalating the saga’s complexity, while Yorgos Lanthimos’ Bugonia—a 2003 remake with Emma Stone and Jesse Plemons—twists sci-fi comedy into absurdity. These directors thrive on personal stamps, not committee notes.
Genre Mash-Ups and Format Experiments
- Musicals reborn: Wicked‘s $600 million-plus haul validates stage-to-screen leaps, paving for Emilia Pérez, Jacques Audiard’s Spanish-language trans opera about a narco boss’s gender transition, which swept Cannes.
- Horror hybrids: Longlegs‘ occult chiller blended slow-burn dread with Nicolas Cage mania, hitting $108 million worldwide.
- Animated risks: Netflix’s The Wild Robot soared with emotional depth beyond kid fare.
These experiments pay off: Deadpool & Wolverine succeeded by subverting superhero norms with meta-humour and R-rated edge, grossing $1.3 billion.
Behind-the-Scenes Shifts Fueling the Fire
Streaming wars wane as Netflix, Amazon, and Apple pivot to theatrical releases for prestige. Apple’s Wolfs with Brad Pitt and George Clooney ditched streaming for cinemas after test buzz. Box office recovery post-strikes demands hits, prompting riskier investments. Agents like CAA push originals, while festivals like Telluride and TIFF amplify discoveries.
Financially, tax incentives lure shoots abroad, slashing costs for ambitious projects. Vertical integration—studios owning distribution—allows tolerance for slower burns. Yet challenges persist: marketing originals remains tough against IP juggernauts. Still, successes like Barbie‘s ironic feminism ($1.4 billion) show smart risks scale.
The Global Perspective and Cultural Stakes
International voices amplify boldness. India’s RRR inspired Hollywood crossovers, while Japan’s Godzilla Minus One won an Oscar on $15 million. 2025 brings Mufasa with global appeal, but originals like The Monkey (Stephen Graham Jones adaptation) tap horror’s universal fears. Culturally, risks address representation: Emilia Pérez spotlights trans and Latino stories, Anora working-class grit.
Audience data from Nielsen reveals Gen Z’s preference for “authentic” tales over polished franchises, driving social media virality. This democratises discovery, pressuring studios to innovate.
Challenges Ahead: Can the Momentum Hold?
Not without hurdles. Budget bloat plagues tentpoles—Mickey 17‘s $100 million-plus demands hits. P&A costs for unknowns soar, and VOD cannibalisation looms. Yet optimists cite 1970s New Hollywood: risks birthed The Godfather, Jaws. Today’s streamers as financiers mirror United Artists’ model.
Predictions? 2025’s slate—Avatar: Fire and Ash safe, but flanked by 28 Years Later‘s zombie revival and The Battle of Baktan Cross‘s war epic—balances portfolios. If Mickey 17 and Eddington deliver, expect a flood of greenslights.
Conclusion
Hollywood’s risk renaissance heralds exciting times. By embracing originals, bold directors, and genre twists, the industry recaptures magic lost to sequel overload. Hits like The Substance and Anora prove audiences reward courage, while upcoming gambles like Mickey 17 test the waters further. As studios learn to balance blockbusters with breakthroughs, cinema’s future brightens. Will your next theatre trip be a franchise rerun or a daring discovery? The choice is Hollywood’s—and ours.
References
- Box Office Mojo, “2024 Domestic Top 10 Analysis,” accessed October 2024.
- Variety, “A24’s 2025 Slate Signals Indie Risk Boom,” September 2024.
- The Hollywood Reporter, “Studio Execs on Post-Franchise Strategies,” August 2024.